newsfilter
← Latest News
Business Wire·

Crown Laboratories Completes Acquisition of Revance Therapeutics

Yesterday, Crown Laboratories, Inc. ("Crown"), a Hildred Capital portfolio company and privately held, global innovative leader in the skincare industry, announced the closing of its acquisition of Revance